SCHEMBL2752064

SCHEMBL2752064

Cc1ccc(Oc2cn[c]s2)cc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HAO1 Q9UJM8 2/20 0.44
KMT2A Q03164 5/20 0.39
MEN1 O00255 3/20 0.39
MAPT P10636 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HPGD P15428 1/20 0.39
HTR2A P28223 5/20 0.38
SLC6A4 P31645 5/20 0.38
L3MBTL1 Q9Y468 2/20 0.36
LMNA P02545 1/20 0.36
GFER P55789 1/20 0.36
KCNH2 Q12809 4/20 0.35
ALDH1A1 P00352 3/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RAB9A P51151 2/20 0.34
TDP1 Q9NUW8 1/20 0.33
HTT P42858 1/20 0.33
KDM4E B2RXH2 1/20 0.31
POLB P06746 1/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2750533 0.78 CA2 (0.47) SMN1; SMN2L3MBTL1LMNAALDH1A1HTT
SCHEMBL2751328 0.77 ALDH1A1 (0.37) SMN1; SMN2ALDH1A1NPSR1TDP1POLB
SCHEMBL2752412 0.74 ALDH1A1 (0.41) MAPTALDH1A1RAB9ANPC1
SCHEMBL17028985 0.74 HAO1 (0.40) HAO1KMT2AMEN1MAPTSMN1; SMN2
SCHEMBL2750961 0.73 CYP19A1 (0.49) SMN1; SMN2HPGDALDH1A1NPSR1
SCHEMBL17028979 0.73 LTA4H (0.42) HAO1KMT2AMEN1MAPTSMN1; SMN2
SCHEMBL2752936 0.72 HSP90AA1 (0.35) KMT2AMEN1SMN1; SMN2HTR2ASLC6A4
SCHEMBL4002816 0.71 HAO1 (0.45) HAO1KMT2AMEN1MAPTSMN1; SMN2
SCHEMBL47874 0.71 KMT2A (0.57) HAO1KMT2AMEN1MAPTSMN1; SMN2
SCHEMBL2751332 0.70 MAPT (0.31) KMT2AMEN1MAPTL3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178540-B2 Pyrimidylmethyl-sulfonamide compounds BASF SE (DE) 2012-05-15 US disclosed
US-20100077512-A1 Pyridazin-4-ylmethyl-sulfonamides used as Fungicides and Against Arthropods BASF SE (DE) 2010-03-25 US disclosed
US-20100069243-A1 Pyrimidylmethyl-Sulfonamide Compounds BASF SE (DE) 2010-03-18 US disclosed
EP-2064190-A1 PYRIMIDYLMETHYL-SULFONAMIDE COMPOUNDS USEFUL AS FUNGICIDES AND AGAINST ARTHROPODS BASF SE (DE) 2009-06-03 EP disclosed
WO-2008062011-A1 PYRIMIDYLMETHYL-SULFONAMIDE COMPOUNDS USEFUL AS FUNGICIDES AND AGAINST ARTHROPODS BASF SE (DE) 2008-05-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069243-A1 Pyrimidylmethyl-Sulfonamide Compounds TPMT, NISCH, PPA1 HAO1 1223/4885KMT2A 702/4885MEN1 2487/4885
US-20100077512-A1 Pyridazin-4-ylmethyl-sulfonamides used as Fungicides and Against Arthropods PIR, PRDX4, PRDX2 HAO1 709/4885KMT2A 388/4885MEN1 2802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.